Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/11/2023 | Bright Health Group Inc. | BHG | Purchase | Warrant (Right to Buy) | 828.4k | $0.01 | $8.3k | See Note 3 | 08/11/2023 |
07/17/2023 | Savara Inc | SVRA | Purchase | Common Stock | 333.3k | $3.00 | $1000k | See Note 2 | 07/17/2023 |
06/28/2023 | Trevi Therapeutics, Inc. | TRVI | Grant | Nonstatutory Stock Option (right to buy) | 30k | $2.27 | $68.1k | | 06/28/2023 |
06/06/2023 | Reneo Pharmaceuticals, Inc. | RPHM | Grant | Stock Option (right to buy) | 17.5k | $9.01 | $157.7k | | 06/06/2023 |
03/02/2023 | RHYTHM PHARMACEUTICALS, INC. | RYTM | Other (acquisition) | Common Stock | 5.8k | $0.00 | $0 | See Note 2 | 03/02/2023 |
12/01/2022 | Akouos, Inc. | AKUS | Disposition | Stock Option (right to buy) | 16k | $4.21 | $67.4k | | 12/01/2022 |
07/13/2022 | Senti Biosciences, Inc. | | Grant | Stock Option (Right to Buy) | 125k | $1.75 | $218.8k | | 07/13/2022 |
06/23/2022 | Trevi Therapeutics, Inc. | TRVI | Grant | Nonstatutory Stock Option (right to buy) | 20k | $2.27 | $45.4k | | 06/23/2022 |
06/23/2022 | Akouos, Inc. | AKUS | Grant | Stock Option (right to buy) | 16k | $4.21 | $67.4k | | 06/23/2022 |
06/10/2022 | Inozyme Pharma, Inc. | INZY | Grant | Stock Option (right to buy) | 9.4k | $4.38 | $41k | | 06/10/2022 |
06/09/2022 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (right to buy) | 27k | $1.17 | $31.6k | | 06/09/2022 |
06/08/2022 | RHYTHM PHARMACEUTICALS, INC. | RYTM | Grant | Stock Option (right to buy) | 20k | $4.15 | $83k | | 06/08/2022 |
06/02/2022 | Mirum Pharmaceuticals, Inc. | MIRM | Grant | Stock Option (right to buy) | 17k | $23.51 | $399.7k | | 06/02/2022 |
06/01/2022 | Reneo Pharmaceuticals, Inc. | RPHM | Grant | Stock Option (right to buy) | 17.5k | $2.09 | $36.6k | | 06/01/2022 |
04/11/2022 | Trevi Therapeutics, Inc. | TRVI | Grant | Common Stock | 948.9k | $1.90 | $1.8M | See Note 2 | 04/11/2022 |
04/11/2022 | Trevi Therapeutics, Inc. | TRVI | Grant | Pre-Funded Warrants | 3M | $0.00 | $3k | See Note 2 | 04/11/2022 |
06/28/2021 | Monte Rosa Therapeutics, Inc. | | Conversion | Common Stock | 2.7M | $0.00 | $0 | See Note 2 | 06/28/2021 |
06/28/2021 | Monte Rosa Therapeutics, Inc. | | Conversion | Common Stock | 3.3M | $0.00 | $0 | See Note 2 | 06/28/2021 |
06/28/2021 | Monte Rosa Therapeutics, Inc. | | Conversion | Common Stock | 669k | $0.00 | $0 | See Note 2 | 06/28/2021 |
06/28/2021 | Monte Rosa Therapeutics, Inc. | | Purchase | Common Stock | 1M | $19.00 | $20M | See Note 2 | 06/28/2021 |
06/28/2021 | Monte Rosa Therapeutics, Inc. | | Conversion | Series A-2 convertible preferred stock | 9.6M | $0.00 | $0 | See Note 2 | 06/28/2021 |
06/28/2021 | Monte Rosa Therapeutics, Inc. | | Conversion | Series B convertible preferred stock | 11.5M | $0.00 | $0 | See Note 2 | 06/28/2021 |
06/28/2021 | Monte Rosa Therapeutics, Inc. | | Conversion | Series C convertible preferred Stock | 2.4M | $0.00 | $0 | See Note 2 | 06/28/2021 |
06/24/2021 | Akouos, Inc. | AKUS | Grant | Stock Option (right to buy) | 16k | $13.39 | $214.2k | | 06/24/2021 |
06/23/2021 | Inozyme Pharma, Inc. | INZY | Grant | Stock Option (right to buy) | 9.4k | $17.12 | $160.4k | | 06/23/2021 |
06/16/2021 | Trevi Therapeutics, Inc. | TRVI | Grant | Nonstatutory Stock Option (right to buy) | 20k | $2.25 | $45k | | 06/16/2021 |
06/10/2021 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (right to buy) | 15k | $3.67 | $55k | | 06/10/2021 |
06/09/2021 | RHYTHM PHARMACEUTICALS, INC. | RYTM | Grant | Stock Option (right to buy) | 15k | $18.99 | $284.8k | | 06/09/2011 |
06/09/2021 | RHYTHM PHARMACEUTICALS, INC. | RYTM | Grant | Stock Option (right to buy) | 15k | $18.99 | $284.8k | | 06/09/2021 |
06/04/2021 | Mirum Pharmaceuticals, Inc. | MIRM | Grant | Stock Option (right to buy) | 17k | $16.88 | $287k | | 06/04/2021 |
04/08/2021 | Reneo Pharmaceuticals, Inc. | RPHM | Grant | Stock Option (right to buy) | 14k | $15.00 | $210k | | 04/08/2021 |
07/23/2020 | Inozyme Pharma, Inc. | INZY | Grant | Stock Option (right to buy) | 9.4k | $16.00 | $149.9k | | 07/23/2020 |
06/17/2020 | RHYTHM PHARMACEUTICALS, INC. | RYTM | Grant | Stock Option (right to buy) | 18.5k | $21.37 | $395.3k | | 06/17/2020 |
06/11/2020 | Trevi Therapeutics, Inc. | TRVI | Grant | Nonstatutory Stock Option (right to buy) | 14.2k | $4.10 | $58.3k | | 06/11/2020 |
06/11/2020 | Mirum Pharmaceuticals, Inc. | MIRM | Grant | Stock Option (right to buy) | 17k | $16.71 | $284.1k | | 06/11/2020 |
|